David Mountcastle Sells 21,275 Shares of Privia Health Group (NASDAQ:PRVA) Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CFO David Mountcastle sold 21,275 shares of the business’s stock in a transaction that occurred on Thursday, July 9th. The shares were sold at an average price of $27.67, for a total transaction of $588,679.25. Following the completion of the transaction, the chief financial officer directly owned 164,853 shares of the company’s stock, valued at approximately $4,561,482.51. This represents a 11.43% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

David Mountcastle also recently made the following trade(s):

• On Tuesday, July 7th, David Mountcastle sold 600 shares of Privia Health Group stock. The stock was sold at an average price of $27.57, for a total transaction of $16,542.00.
• On Thursday, July 2nd, David Mountcastle sold 24,734 shares of Privia Health Group stock. The stock was sold at an average price of $27.50, for a total transaction of $680,185.00.
• On Friday, June 26th, David Mountcastle sold 17,196 shares of Privia Health Group stock. The shares were sold at an average price of $25.18, for a total value of $432,995.28.
• On Monday, May 11th, David Mountcastle sold 3,385 shares of Privia Health Group stock. The stock was sold at an average price of $22.60, for a total value of $76,501.00.
• On Monday, May 4th, David Mountcastle sold 1,206 shares of Privia Health Group stock. The stock was sold at an average price of $25.00, for a total value of $30,150.00.
• On Friday, May 1st, David Mountcastle sold 7,179 shares of Privia Health Group stock. The stock was sold at an average price of $25.03, for a total value of $179,690.37.

Privia Health Group Stock Up 1.5%

Shares of NASDAQ:PRVA traded up $0.41 during midday trading on Monday, reaching $27.90. The company’s stock had a trading volume of 1,035,444 shares, compared to its average volume of 940,061. The firm has a market cap of $3.52 billion, a price-to-earnings ratio of 174.39, a price-to-earnings-growth ratio of 2.17 and a beta of 0.83. The business has a 50 day moving average price of $23.76 and a 200 day moving average price of $23.14. Privia Health Group, Inc. has a 1 year low of $18.77 and a 1 year high of $27.96.

Wall Street Analyst Weigh In

A number of research firms have recently commented on PRVA. Canaccord Genuity Group dropped their price objective on shares of Privia Health Group from $35.00 to $34.00 and set a “buy” rating for the company in a research note on Friday, May 8th. Evercore set a $26.00 target price on shares of Privia Health Group in a research report on Wednesday, April 8th. Barclays lowered their target price on shares of Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating for the company in a report on Tuesday, May 26th. Zacks Research lowered shares of Privia Health Group from a “hold” rating to a “strong sell” rating in a research report on Tuesday, July 7th. Finally, Weiss Ratings upgraded shares of Privia Health Group from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, July 2nd. Eleven analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Privia Health Group currently has an average rating of “Moderate Buy” and an average target price of $31.15.

Hedge Funds Weigh In On Privia Health Group

Several hedge funds and other institutional investors have recently modified their holdings of PRVA. Bayban acquired a new stake in Privia Health Group during the 4th quarter worth approximately $26,000. Hantz Financial Services Inc. grew its stake in Privia Health Group by 456.2% during the fourth quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company’s stock worth $27,000 after buying an additional 926 shares during the period. Global Retirement Partners LLC increased its position in shares of Privia Health Group by 579.8% in the fourth quarter. Global Retirement Partners LLC now owns 1,584 shares of the company’s stock worth $38,000 after acquiring an additional 1,351 shares in the last quarter. Harbor Investment Advisory LLC purchased a new position in shares of Privia Health Group in the 2nd quarter valued at $69,000. Finally, Canada Pension Plan Investment Board raised its stake in shares of Privia Health Group by 48.0% in the 2nd quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock valued at $85,000 after acquiring an additional 1,200 shares during the period. 94.48% of the stock is owned by institutional investors and hedge funds.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.